Viewing Study NCT03994016


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT03994016
Status: COMPLETED
Last Update Posted: 2024-12-05
First Post: 2019-05-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the WiseGuyz Program for Adolescent Boys
Sponsor: University of Calgary
Organization:

Study Overview

Official Title: Preventing Adolescent Dating Violence Through Gender-Transformative Healthy Relationships Promotion: The WiseGuyz Program
Status: COMPLETED
Status Verified Date: 2024-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adolescent dating violence (ADV) is a pressing public health problem in North America, and strategies to prevent perpetration are needed. To this end, a substantial body of research demonstrates the importance of applying a gender lens to target root causes of ADV. To date, however, there has been limited research on how to specifically engage boys in ADV prevention. As such, this protocol describes the evaluation of a program called WiseGuyz, a community-facilitated, gender-transformative healthy relationships program for mid-adolescent (\~ages 13-15) male-identified youth. WiseGuyz aims to reduce male-perpetrated ADV, and improve mental and sexual health, by helping participants identify and deconstruct male gender role norms, and explore healthier, more inclusive ways of being a guy in the world. The primary goal of this evaluation is to explore the impact of WiseGuyz on ADV outcomes among mid-adolescent male-identified youth, using a mixed-methods, longitudinal, quasi-experimental design with a matched comparison group.
Detailed Description: Study Design and Overview:

In this project, the investigators will examine the association between participation in the WiseGuyz program and ADV outcomes. The investigators will use a mixed-methods, quasi-experimental design with pre-test, post-test and one-year follow-up surveys, engaging participants from two Western Canadian school divisions. Through focus groups with youth participants, the investigators will contextualize quantitative survey data, to deepen understanding of how WiseGuyz may promote the prevention of ADV.

Participants:

The investigators plan to recruit approximately 700-800 grade nine male-identified youth in 7 participating schools.

Procedures:

The investigators will make presentations on the research project to all grade 9 youth at participating schools. Any male-identified youth in grade 9 is welcome to participate, regardless of their involvement with WiseGuyz. Interested participants will need to provide signed parent/guardian consent (paper or electronic) and themselves complete an assent form to participate in the research. Quantitative data will be collected in three cohorts (Cohort One - pre-test: October 2019; post-test: May 2020; one-year follow-up: May 2021; Cohort Two - pre-test: October 2021; post-test: May 2022; one-year follow-up: May 2023; Cohort Three - pre-test: October 2022; post-test: May 2023; one-year follow-up: May 2024). An additional cohort needed to be added due to COVID-19 related study disruptions in 2019-20, 2020-21, and 2021-22.

The investigators will gather qualitative focus group data from approximately 60 WiseGuyz participants immediately post-intervention. Cohort One focus groups will occur in May 2020, Cohort Two focus groups will occur in May 2021. The investigators will also interview school leadership in Spring 2021. \*note: due to COVID-19 disruptions, focus groups/interviews will only occur with Cohort 3 in Spring 2023\*

To understand program implementation, implementation tracking data will be collected at the start of the program year, immediately following each WiseGuyz session, at the end of each WiseGuyz module, and at the end of the program year. The investigators will collect these data from October 2019-May 2023.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: